J.ophthalmol.(Ukraine).2019;6:15-22.

http://doi.org/10.31288/oftalmolzh201961522

Received: 17 September 2019; Published on-line: 31 December 2019


Value of TNF-α (rs1800629) polymorphism in recurrent maculopathy after surgery in a Ukrainian population of T2DM patients

Iu.O. Panchenko, Cand Sc (Med)

Kyiv Municipal Clinical Hospital “Eye Microsurgery Center”; Kyiv (Ukraine)

Laser Plus Medical Center; Lviv (Ukraine)

E-mail: panchenko0802@gmail.com

TO CITE THIS ARTICLE: Panchenko IuO. Value of TNF-α (rs1800629) polymorphism in recurrent maculopathy after surgery in a Ukrainian population of T2DM patients. J.ophthalmol.(Ukraine).2019;6:15-22. http://doi.org/10.31288/oftalmolzh201961522


Background: Tumor necrosis factor alpha (TNFα) induces insulin resistance in type 2 diabetes mellitus (T2DM). TNF-α -308G/A (rs1800629) polymorphism is associated with T2DM and its complications (particularly, diabetic retinopathy (DR) and diabetic maculopathy (DMP)) since it contributes to TNF-α expression.

Purpose: To investigate the value of TNF-α (rs1800629) polymorphism in recurrent DMP after surgery in a Ukrainian population of patients with T2DM.

Materials and Methods: The study included 313 patients with T2DM (313 eyes) and diabetic maculopathy. These included patients with mild nonproliferative DR (NPDR; n=40), moderate or severe NPDR (n=92), and proliferative DR (PDR; n=181). Patients received one of the four types of surgical treatment: only three-port closed subtotal vitrectomy (CSTV; n=78); CSTV combined with internal limiting membrane (ILM) peeling (n=85); CSTV combined with ILM peeling and panretinal laser coagulation (PRLC) (n=81); and CSTV combined with ILM peeling, PRLC and cataract phacoemulsification (phaco) (n=69). Baseline blood TNF-α levels were measured by enzyme-linked immunosorbent assay and rs1800629 was investigated by polymerase chain reaction. Statistical analyses were conducted using Statistica 10.0 (StatSoft, Tulsa, OK, USA) software.

Results: In patients with DMP, rs1800629 was associated with the development and recurrence of DMP after surgery. Recurrent DMP developed in 96.9% of A/A genotype carriers. Heterozygous G/A genotype carriers had an increased risk (OR = 3.76; 95% CI: 2.27-6.27), whereas homozygous ancestral G/G genotype carriers, a decreased risk (OR = 0.02; 95% CI: 0.01-0.06) for recurrent DMP. TNF-α rs1800629 A-allele carriage was associated with macular edema. Among study patients, central retinal thickness was highest in A-allele carriers, both at baseline and after surgery, and did not decrease in these carriers within the follow-up period.

Conclusion: An elevated TNFα blood level in carriers of the minor A-allele of the TNFα rs1800629 polymorphism was a factor promoting recurrent DMP after surgery.

Keywords: diabetic maculopathy, type 2 diabetes mellitus, surgical treatment, recurrence, TNF-α, rs1800629

References

1.Pankiv VI. [Workshop No. 162. Diabetes mellitus: Diagnostic criteria, etiology and pathogenesis]. Mizhnarodnyi endokrynologichnyi zhurnal. 2013;8:53-64. Ukrainian.

2.Type 2 Diabetes Complications. Web-resource: https://www. endocrineweb.com/conditions/type-2-diabetes/type-2-diabetes-complications

3.Balashevich LI, Izmailov AS. [Diabetic ophthalmopathy]. St Petersburg: Chelovek; 2012. Russian.

4.Liu C, Feng X, Li Q, Wang Y, Li Q, Hua M. Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: A systematic review and meta-analysis. Cytokine. 2016 Oct;86:100-9. 

Crossref   PubMed

5.IRS1 – Insulin receptor substrate 1 – Homo sapiens (Human) – IRS1 gene & protein". www.uniprot.org. Retrieved 2016-04-21.

6.Takaguri A. [Elucidation of a new mechanism of onset of insulin resistance: effects of statins and tumor necrosis factor-α on insulin signal transduction]. Yakugaku Zasshi. 2018;138(11):1329-1334. Japanese.

Crossref   PubMed 

7.Copps KD, White MF. Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia. 2012;55(10):2565-82. 

Crossref   PubMed

8.Jamil K, Jayaraman A, Ahmad J, Joshi S, Yerra SK. TNF-alpha -308G/A and -238G/A polymorphisms and its protein network associated with type 2 diabetes mellitus. Saudi J Biol Sci . 2017 Sep;24(6):1195-1203. 

Crossref   PubMed  

9.Liu ZH, Ding YL, Xiu LC, Pan HY, Liang Y, Zhong SQ, Liu WW, Rao SQ, Kong DL. A meta-analysis of the association between TNF-α -308G>A polymorphism and type 2 diabetes mellitus in Han Chinese population. PLoS One. 2013;8(3):e59421. 

Crossref   PubMed

10.Sesti LF, Crispim D, Canani LH, Polina ER, Rheinheimer J, Carvalho PS, Gross JL, Santos KG. The -308G>A polymorphism of the TNF gene is associated with proliferative diabetic retinopathy in Caucasian Brazilians with type 2 diabetes. Invest Ophthalmol Vis Sci. 2015 Jan 29;56(2):1184-90. 

Crossref   PubMed 

11.Dhamodharan U, Viswanathan V, Krishnamoorthy E, Rajaram R, Aravindhan V. Genetic association of IL-6, TNF-α and SDF-1 polymorphisms with serum cytokine levels in diabetic foot ulcer. Gene. 2015 Jul 1;565(1):62-7. 

Crossref   PubMed  

12.Doody NE, Dowejko MM, Akam EC, Cox NJ, Bhatti JS, Singh P, Mastana SS. The role of TLR4, TNF-α and IL-1β in type 2 diabetes mellitus development within a North Indian population. Ann Hum Genet. 2017 Jul;81(4):141-146. 

Crossref   PubMed  

13.Luna GI, da Silva IC, Sanchez MN. Association between -308G/A TNFA Polymorphism and Susceptibility to Type 2 Diabetes Mellitus: A Systematic Review. J Diabetes Res. 2016;2016:6309484.

Crossref    PubMed 

14.Mogilevskyy SIu, Panchenko IuA. [Features of diabetic maculopathy in patients with type 2 diabetes mellitus]. Arkhiv oftalmologii Ukrainy. 2018;6(2 (11)): 28-32. Russian.

15.Mogilevskyy SIu, Panchenko IuO, Ziablytsev SV. Predicting the risk of diabetic retinopathy-assosiated macular edema in patients with type 2 diabetes mellitus. Journal of Ophthalmology (Ukraine). 2019;3(488):3-8. 

Crossref   

16.Early Treatment Diabetic Retinopathy Study Research design and baseline patient characteristics. ETDRS, report number 7. Ophthalmology. 1991; 98(5) Suppl.:741-56. 

Crossref  

17.Zhao Y, Li Z, Zhang L, Zhang Y, Yang Y, Tang Y, Fu P. The TNF-alpha -308G/A polymorphism is associated with type 2 diabetes mellitus: an updated meta-analysis. Mol Biol Rep. 2014 Jan;41(1):73-83. 

Crossref   PubMed  

18.Hameed I, Masoodi SR, Malik PA, Mir SA, Ghazanfar K, Ganai BA. Genetic variations in key inflammatory cytokines exacerbates the risk of diabetic nephropathy by influencing the gene expression. Gene. 2018 Jun 30;661:51-59. 

Crossref   PubMed  

19.Umapathy D, Krishnamoorthy E, Mariappanadar V, Viswanathan V, Ramkumar KM. Increased levels of circulating (TNF-α) is associated with (-308G/A) promoter polymorphism of TNF-α gene in Diabetic Nephropathy. Int J Biol Macromol. 2018 Feb;107(Pt B):2113-2121. 

Crossref   PubMed  

 

Conflict of Interest: The authors declare no conflicts of interest with regard to this paper.